A video densitometric analysis of viral burden and follicular dendritic cell damage in lymph nodes in the latency phase of HIV infection

C Zannini, A Favre, E Ciccone… - … : The Journal of the …, 2000 - Wiley Online Library
C Zannini, A Favre, E Ciccone, A Plebani, M Duse, CE Grossi, C Pesce
Cytometry: The Journal of the International Society for Analytical …, 2000Wiley Online Library
Background The aim of this study was to collect quantitative data on damage to follicular
dendritic cells (FDC) and on the structure of germinal centers (GC) in the early phase of HIV
infection. Methods Lymph node sections from 10 HIV+ subjects and from 5 HIV‐control
subjects were stained by immunohistochemistry for CD21, an FDC marker; gp24, to assess
the HIV load; and IgM, to measure antibodies within the GC. Results The volume fraction
(Varea) and the logarithm of the inverse gray value (ArLIGV) of CD21 areas showed a highly …
Background
The aim of this study was to collect quantitative data on damage to follicular dendritic cells (FDC) and on the structure of germinal centers (GC) in the early phase of HIV infection.
Methods
Lymph node sections from 10 HIV+ subjects and from 5 HIV control subjects were stained by immunohistochemistry for CD21, an FDC marker; gp24, to assess the HIV load; and IgM, to measure antibodies within the GC.
Results
The volume fraction (Varea) and the logarithm of the inverse gray value (ArLIGV) of CD21 areas showed a highly significant decrease in HIV+ specimens. The mean ArLIGV values ranged between 0.0916 ± 0.01 and 0.3826 ± 0.11 versus 0.6856 ± 0.19 on average in controls (P < 0.001 for both). Six of 10 HIV+ specimens were positive for gp24. Staining was limited to GC and showed a distribution pattern similar to that of CD21.
Conclusions
FDC already undergo considerable damage during the latency phase of HIV infection. The pattern of CD21 indicates that, although FDC decrease in number, the staining intensity of positive cells is basically preserved. Video densitometric analysis, an approach requiring a strict standardized protocol, may help monitor disease course and evaluate response to therapy by quantifying viral burden and lymph node damage. Cytometry 40:209–213, 2000 © 2000 Wiley‐Liss, Inc.
Wiley Online Library